Researchers Push Back Against Overhauling Clinical Trials
نویسندگان
چکیده
منابع مشابه
Researchers Turn to Canine Clinical Trials to Advance Cancer Therapies.
About 6 million dogs are diagnosed with cancer each year, and more thanhalfofdogsolder than 10years will develop cancers such as osteosarcoma, lymphoma, or melanoma (http://1.usa.gov /1OAxijB). But the heartbreaking diagnosis for dog owners is a treasure trove of potential data for oncology researchers. In clinical trials at academic research centers across the country, veterinarians and physic...
متن کاملEvaluation of Clinical Trials
In a number of important clinical issues such as evaluation of the efficacy or effectiveness of therapeutic or preventive interventions as well as for comparing the harms of interventions, randomized controlled trials (RCTs) provide the highest levels of evidence, either directly or indirectly. It is obvious that critical appraisal of these studies to assess their validity and precision is of p...
متن کاملEvidence Based Medicine: Clinical Trials
Evidence based medicine is very important for success of modern medicine. It is the ongoing process of using the most reliable evidence from clinical studies, scientific understanding and medical practice to make the best possible medical choice for patients. Evidence based medicine is how medicine advances and how we get improvements in life expectancy and quality of life. It not only identifi...
متن کاملNutrients for prevention: negative trials send researchers back to drawing board.
T he dream of preventing cancer with a vitamin pill is rapidly evaporating. Over the past few months, results from clinical trials and observational studies report no benefit — and in a few cases, possible harm — from supplementation with several micronutrients, including vitamins C, D, and E; selenium; calcium; and folate. The fi ndings have sobered investigators in the fi eld of chemopreventi...
متن کاملClinical stroke trials: guarding against bias.
presentation, purportedly based on concerns about the accuracy of the information. Because of contractual agreements with the investigators, the industry sponsor maintained a right to block public disclosure. Although we are not privy to the details of the circumstances prompting this episode, it may represent one of the most blatant recent examples of the potential negative side of academic-in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2014
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/dju274